Valuation: IRADIMED CORPORATION

Market Cap 1.18B 1.02B 957M 875M 1.65B 113B 1.67B 11.22B 4.4B 56.43B 4.44B 4.34B 188B P/E 2026 *
48.2x
P/E 2027 * 41.7x
Enterprise Value 1.18B 1.02B 957M 875M 1.65B 113B 1.67B 11.22B 4.4B 56.43B 4.44B 4.34B 188B EV / Sales 2026 *
13x
EV / Sales 2027 * 11.7x
Free-Float
64.79%
Yield 2026 *
-
Yield 2027 * -
1 day-0.84%
1 week+0.46%
Current month+1.23%
1 month-5.37%
3 months+9.08%
6 months-12.52%
Current year-5.45%
1 week 90.14
Extreme 90.14
94.73
1 month 89.51
Extreme 89.51
98.61
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
30/03/26 Sell

Chief Executive Officer

7,500 0.0590%
13/02/26 Sell

Director

1,000 0.0079%
26/01/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
-2.65%+0.46%+31.40%+93.76% 1.18B
+0.13%-2.44%-13.77%-17.10% 13.68B
-6.06%+7.72%+43.44%-2.22% 4.47B
+0.59%+1.04%-38.22%-52.65% 1.28B
0.00%+1.50%-34.34%-39.45% 1.2B
+1.57%+3.13%-43.22% - 968M
-1.00%+22.85%+52.90%+159.25% 622M
-5.77%-4.88%+65.94% - 355M
+2.21%-0.13%-59.56%+261.36% 259M
+12.30%+34.34%+50.21%+88.36% 164M
Average +0.46%+3.41%+5.48%+61.41% 2.42B
Weighted average by Cap. -0.98%+0.46%-1.64%-2.90%

Financials

2026 *2027 *
Net sales 91.2M 78.95M 73.8M 67.45M 127M 8.7B 129M 865M 340M 4.35B 342M 335M 14.49B 101M 87.44M 81.73M 74.69M 141M 9.63B 143M 958M 376M 4.82B 379M 371M 16.05B
Net income 24.65M 21.34M 19.95M 18.23M 34.35M 2.35B 34.89M 234M 91.78M 1.18B 92.56M 90.54M 3.92B 28.45M 24.63M 23.02M 21.04M 39.65M 2.71B 40.27M 270M 106M 1.36B 107M 104M 4.52B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
10/08/26 US$90.49 -2.17% 69,188
07/08/26 US$92.50 +1.41% 88,220
06/08/26 US$91.21 -0.71% 94,438
05/08/26 US$91.86 -1.36% 148,482
04/08/26 US$93.13 +1.71% 227,288
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
92.50USD
Average target price
118.00USD
Spread / Average Target
+27.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock